8-hydroxy-5-[(-hydroxy-2-[[ (1R)-2-(4-methoxyphenyl)-1-methylethy l] amino ][ethyl] -2(1H)-quinolinone monohydrochloride in crystalline form and the process for its preparation

Details for Australian Patent Application No. 2005224032 (hide)

Owner Chiesi Farmaceutici S.P.A.

Inventors Pivetti, Fausto; Pighi, Roberto

Agent Lord and Company

Pub. Number AU-A-2005224032

PCT Pub. Number WO2005/089760

Priority 04007045.0 24.03.04 EP

Filing date 24 March 2005

Wipo publication date 29 September 2005

International Classifications

A61K 31/47 (2006.01) - Quinolines

C07D 207/48 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 215/26 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

C07D 215/60 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

Event Publications

12 October 2006 PCT application entered the National Phase

  PCT publication WO2005/089760 Priority application(s): WO2005/089760

20 October 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005224034-Fungicide composition comprising an arylamidine derivative and known fungicide compounds

2005224031-Shelf stable product with living microorganisms